Monitoring and Cognitive Appraisal: The Etiology of Psychological Disorders and The Divergence Between Behavioural and Self-reported Data

NCT07137676 | Completed

• 2 other identifiers: file reference 2024-01kethics comittee
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

The study investigates the etiology of psychogical disorders from a neuropsychological perspective based on monitoring and cognitive appraisal.

Conditions

Geriatric Patients in a Pre-rehabilitative Treatment; Mild Cognitive Impairment (MCI)

Keywords

monitoring; cognitive appraisal

Outcome Measures

Primary Outcomes (4)

• AX-CPT (AX-Continuous Performance Test)

  The AX-CPT assesses cognitive control through error rates and reaction times. Range: Error rate: 0-100%; Reaction time: measured in milliseconds Interpretation: Lower error rates and faster reaction times indicate better cognitive control performance.

  from beginning (day 2) of the hospitalization to the end (day 14) of the biweekly pre-rehabilitative treatment.

• CCFQ (Cognitive Control and Flexibility Questionnaire)

  The CCFQ measures self-reported cognitive flexibility and control. Scale title: Cognitive Control and Flexibility Questionnaire Range: 1-7 per item Interpretation: Higher scores indicate greater cognitive flexibility and control.

  Day 1 (pretest) and Day 14 (posttest)

• BSI-18 (Brief Symptom Inventory - 18)

  T he BSI-18 assesses psychological symptom severity in terms of depression, anxiety, and somatization.T Scale title: Brief Symptom Inventory - 18 Range: 0-4 per item Interpretation: Higher scores indicate greater symptom severity.

  Day 1 (pretest) and Day 14 (posttest)

• MHC-SF (Mental Health Continuum - Short Form)

  Measures emotional, psychological, and social well-being. Range: 1-6 per item Interpretation: Higher scores indicate better mental health.

  Day 1 (pretest) and Day 14 (posttest)

Secondary Outcomes (2)

• General Self-Efficacy assessed via General Self-Efficacy Scale (SWE)

  Day 1 (pretest) and Day 14 (posttest)

• Treatment Beliefs assessed via Palermo Questionnaire

  Day 1 (pretest) and Day 14 (posttest)

Study Arms (2)

AX-CPT Treatment

EXPERIMENTAL

Treatment with the AX-CPT

Behavioral: AX-CPT

Control Group

OTHER

AX-CPT is merely administrated as pre-and posttest measure.

Other: No Interventions

Interventions

AX-CPT BEHAVIORAL

administration of the AX-CPT

AX-CPT Treatment

No Interventions OTHER

Control group with no intervention treatment

Control Group

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Older Adult (65+)

You may qualify if:

• geriatric patient of the St. Franziskus-Hospital, Germany.

You may not qualify if:

• severe dementia
• delirium
• psychotic disorders

Sponsors & Collaborators

• St. Franziskus Hospital: lead

Study Sites (1)

St. Franziskus-Hospital Winterberg

Winterberg, North Rhine-Westphalia, 59955, Germany

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Interventions

Neuropsychological Tests

Condition Hierarchy (Ancestors)

Cognition Disorders; Neurocognitive Disorders; Mental Disorders

Intervention Hierarchy (Ancestors)

Psychological Tests; Behavioral Disciplines and Activities

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: BASIC SCIENCE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Chief Clinical Neuropsychologist (Winterberg, Germany)

Study Record Dates

• First Submitted: July 25, 2025
• First Posted: August 22, 2025
• Study Start: December 16, 2023
• Primary Completion: March 9, 2025
• Study Completion: March 9, 2025
• Last Updated: August 22, 2025

Record last verified: 2025-08

Data Sharing

• IPD Sharing: Will not share

Locations

DE (1)